389 related articles for article (PubMed ID: 27113046)
1. Persistent Increase in Blood Pressure After Renal Nerve Stimulation in Accessory Renal Arteries After Sympathetic Renal Denervation.
de Jong MR; Hoogerwaard AF; Gal P; Adiyaman A; Smit JJ; Delnoy PP; Ramdat Misier AR; van Hasselt BA; Heeg JE; le Polain de Waroux JB; Lau EO; Staessen JA; Persu A; Elvan A
Hypertension; 2016 Jun; 67(6):1211-7. PubMed ID: 27113046
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
3. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
[TBL] [Abstract][Full Text] [Related]
4. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
de Leon-Martinez EP; Garza JA; Azpiri-Lopez JR; Dillon KN; Salazar LO; Canepa-Campos F; Rousselle SD; Tellez A
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):445-8. PubMed ID: 26014838
[TBL] [Abstract][Full Text] [Related]
5. Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.
VonAchen P; Hamann J; Houghland T; Lesser JR; Wang Y; Caye D; Rosenthal K; Garberich RF; Daniels M; Schwartz RS
Cardiovasc Revasc Med; 2016; 17(7):470-473. PubMed ID: 27493150
[TBL] [Abstract][Full Text] [Related]
6. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
[TBL] [Abstract][Full Text] [Related]
7. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
[TBL] [Abstract][Full Text] [Related]
8. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.
Krum H; Schlaich M; Whitbourn R; Sobotka PA; Sadowski J; Bartus K; Kapelak B; Walton A; Sievert H; Thambar S; Abraham WT; Esler M
Lancet; 2009 Apr; 373(9671):1275-81. PubMed ID: 19332353
[TBL] [Abstract][Full Text] [Related]
9. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
10. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
Id D; Kaltenbach B; Bertog SC; Hornung M; Hofmann I; Vaskelyte L; Sievert H
JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968
[TBL] [Abstract][Full Text] [Related]
11. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
[TBL] [Abstract][Full Text] [Related]
12. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP
Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488
[TBL] [Abstract][Full Text] [Related]
13. Renal Nerve Stimulation-Induced Blood Pressure Changes Predict Ambulatory Blood Pressure Response After Renal Denervation.
de Jong MR; Adiyaman A; Gal P; Smit JJ; Delnoy PP; Heeg JE; van Hasselt BA; Lau EO; Persu A; Staessen JA; Ramdat Misier AR; Steinberg JS; Elvan A
Hypertension; 2016 Sep; 68(3):707-14. PubMed ID: 27432864
[TBL] [Abstract][Full Text] [Related]
14. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
Fischell TA; Ebner A; Gallo S; Ikeno F; Minarsch L; Vega F; Haratani N; Ghazarossian VE
JACC Cardiovasc Interv; 2016 Mar; 9(6):589-98. PubMed ID: 27013159
[TBL] [Abstract][Full Text] [Related]
16. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
[TBL] [Abstract][Full Text] [Related]
17. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
[TBL] [Abstract][Full Text] [Related]
18. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
[TBL] [Abstract][Full Text] [Related]
19. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
[TBL] [Abstract][Full Text] [Related]
20. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
Danilov NM; Matchin IuG; Chazova IE
Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
